Rewrite The Rules For Consumer Drug Ads
Prescription-drug advertising was once a simple business. Companies pitched their products only to doctors--and the Food & Drug Administration prescribed ad rules accordingly. That's why all ads that link a product's name to its use must include a "brief summary"--actually a long list of risks, precautions, side effects, and other information that physicians need. But times have changed. With once-fat margins threatened by low-price generic drugs and cost-conscious health insurers, companies are taking the bold step of advertising directly to consumers, hoping that patients will ask their doctors for pricey prescription products.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.